BIM
ZBH icon

Bullseye Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bullseye Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$899 – 338
2025
Q4 		$899 Buy
+10
New +$948 ﹤0.01% 301

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bullseye Investment Management's ZBH Position: Q1 2026 in Review

Bullseye Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 10 shares — an estimated $899 sold.

Bullseye Investment Management first reported a position in ZBH in Q4 2025 and held it in 1 quarter. The position peaked at $899 in Q4 2025. 918 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Bullseye Investment Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Bullseye Investment Management sold 10 Zimmer Biomet shares in Q1 2026, an estimated $899.
  • Bullseye Investment Management first reported a position in Zimmer Biomet in Q4 2025 and held it in 1 quarter.
  • Bullseye Investment Management's Zimmer Biomet position peaked at $899 in Q4 2025.
  • 918 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Bullseye Investment Management's 13F filing for Q1 2026, filed 14 Sep 2026.